U.S. Anesthesia Partners, Inc. Antitrust Litigation
Lieff Cabraser represents plaintiffs in a class action alleging that U.S. Anesthesia Partners, Inc. monopolized the commercially reimbursed hospital-only anesthesia market in Texas. Between 2012 and 2019, USAP acquired sixteen anesthesia practices across Texas as a part of an “aggressive ‘buy and build’ consolidation strategy.” Through those acquisitions, USAP obtained more than 50% of the Texas market. USAP transformed its growing market share and foothold in multiple geographies across Texas into profits. After each acquisition, USAP raised reimbursement rates above competitive levels. As a result, Texas healthcare payors have been illegally overcharged for anesthesia services since 2012.
This class action parallels the Federal Trade Commission’s civil lawsuit against USAP, which alleges that USAP monopolized the commercially reimbursed hospital-only anesthesia market in Texas.
Civil Litigation News
Lieff Cabraser and Kaplan Gore Announce Filing of Federal Class Action Lawsuit Against Google Over the Defective Google Nest Hub, Google Nest Hub Max, Google Nest Mini, and Google Nest Audio Devices
Complaint alleges that Google induced plaintiffs and other customers to spend hundreds of dollars or more each to purchase Google Nest Hub,
Douglas Cuthbertson to Discuss “Consumer Data Privacy” at Upcoming NASCAT Annual Meeting
Lieff Cabraser partner Douglas Cuthbertson will be a featured speaker at the 2025 NASCAT annual meeting. Doug will be speaking on the
San Francisco Schools Receive Financial Boost From Settlement With JUUL
As reported by the S.F. Chronicle, the San Francisco Unified School District has been awarded a substantial $24.65
